Nancy Fern Olivieri | |
|---|---|
| Born | 1954 |
| Nationality | Canadian |
| Alma mater | University of Toronto Harvard University |
| Awards | AAAS Award for Scientific Freedom and Responsibility (2009), John Maddox Prize (2023) |
| Scientific career | |
| Fields | Hematology |
| Institutions | University of Toronto |
Nancy Fern Olivieri (born 1954) is a prominent Toronto haematologist and researcher with an interest in the treatment of haemoglobinopathies. She is best known for a protracted struggle with the Hospital for Sick Children and the pharmaceutical company Apotex about the drug deferiprone.[1]